BeiGene

IPO

One World. One Goal.

Public · Cambridge, United States · Founded 2010 · $2.8B raised

Employees
10001+
Founded
2010
Business Model
B2B
Total Funding
$2.8B
Last Round
$2.8B Corporate RoundJan 2020
Rounds
1
Type
Public

About

BeOne Medicines (formerly BeiGene) is a global oncology company committed to discovering and developing innovative treatments to make a meaningful difference for cancer patients worldwide. With a portfolio of approved medicines across hematologic and solid tumor cancers including BTK inhibitors and anti-PD-1 therapies, BeOne operates research facilities and commercial operations in over 45 countries. The company completed its rebrand from BeiGene to BeOne Medicines in 2025.

Summary

BeiGene is a Biotech company based in Cambridge, United States, founded in 2010. It has raised $2.8B in total across 1 round, most recently a $2.8B Corporate Round round in Jan 2020. Investors include Amgen, Goldman Sachs and Morgan Stanley.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

IPODec 2021
$3.5B

Sign up to see all 5 rounds

IPO — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

BeiGene on Indexed.vc
<a href="https://indexed.vc/companies/beigene"><img src="https://indexed.vc/api/badge/company/beigene" alt="BeiGene on Indexed.vc" width="260" height="76" /></a>